Results 91 to 100 of about 9,537,389 (233)

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents

Antimicrobial Agents and Chemotherapy, 1990
A total of 94 clinical isolates of the Bacteroides fragilis group was tested for susceptibility to metronidazole, chloramphenicol, clindamycin, cefoxitin, cefotetan, cefmetazole, moxalactam, mezlocillin, amoxicillin-clavulanic acid, and imipenem. All the strains tested were susceptible to imipenem, metronidazole, amoxicillin-clavulanic acid, and ...
C, Betriu, E, Campos, C, Cabronero, C, Rodriguez-Avial, J J, Picazo   +4 more
openaire   +3 more sources

Susceptibilities of members of the Bacteroides fragilis group to 11 antimicrobial agents [PDF]

Antimicrobial Agents and Chemotherapy, 1992
The susceptibilities of 200 clinical isolates of the Bacteroides fragilis group to 11 antimicrobial agents were determined by the broth microdilution method of the National Committee for Clinical Laboratory Standards. All isolates were susceptible to imipenem and ticarcillin-clavulanic acid. The rates of resistance to cefoxitin and clindamycin were low
R, Horn, J, Lavallée, H G, Robson
openaire   +2 more sources

Detection of enterotoxigenic Bacteroides fragilis in patients with ulcerative colitis

Gut Pathogens, 2017
Purpose Ulcerative colitis (UC) as a type of inflammatory bowel disease (IBD), presumed to occur as a consequence of increased immune responses to intestinal microbiota in genetically susceptible individuals.
Samin Zamani, Sonia Hesam Shariati, Mohammad Reza Zali, Hamid Asadzadeh Aghdaei, Akram Sarabi Asiabar, Saied Bokaie, Bizhan Nomanpour, Leonardo Antonio Sechi, Mohammad Mehdi Feizabadi   +8 more
doaj   +1 more source

Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges

British Journal of Pharmacology, EarlyView.
This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu, Kaibin Dai, Zhensheng Lin, Mingfang Ye, Minfeng Chen, Xiaobo Li, Dongmei Zhang   +6 more
wiley   +1 more source

Detection of Bacteroides fragilis group by immunofluorescence.

Roumanian archives of microbiology and immunology, 1992
The following strains: B. fragilis subspecies thetaiotaomicron (A); B. fragilis subspecies fragilis strain E-1, E-2, M, St., Se., Ni., 8, 16; B. fragilis subspecies distasonis 145 (D) were serologically studied by immunofluorescence as compared to agglutination. Anti-B.
I, Radu, J, Bittner, A, Macovei, L, Costache, D, Mihalache, V, Munteanu   +5 more
openaire   +1 more source

A guide to host genetic determinants of female microbiome composition across distinct anatomical niches

The FEBS Journal, EarlyView.
Host genetic variation in immune regulation and cell signalling genes was associated with microbiome composition across vaginal, gut, oral and skin sites, while associations involving metabolic function, epithelial barrier integrity and hormonal processes were more site‐specific. Overall, our findings indicate that host genetic variation contributes to
Isabella Margaret Davidson, Elham Nikbakht, Hayley O'Neill, Larisa Margaret Haupt, Paul Joseph Dunn   +4 more
wiley   +1 more source

In Vitro Activities of MK-0826 and 16 Other Antimicrobials against Bacteroides fragilis Group Strains

, 2001
The activity of MK-0826, a new carbapenem, against 309 Bacteroides fragilis group strains was investigated and compared with that of 11 other β-lactam and 5 non-β-lactam agents. MK-0826 showed excellent activity (MICs ranged from ≤
Juan J. Picazo, Marı́a Gómez, Ana Sánchez, Marı́a Luisa Palau, Carmen Betriu   +4 more
core   +1 more source

Virulence factors in Bacteroides fragilis group.

The Indian journal of medical research, 1992
Attempts were made to study the virulence factors in some strains of B. fragilis group in the rat model. Subcutaneous wound abscesses could be produced by 10(9) CFU/ml of live cells of all the five species of B. fragilis group tested. For determination of virulence factor cellular components (capsular polysaccharide and lipopolysaccharide) of B ...
R, Jotwani, U, Gupta
openaire   +1 more source

Gut Microbiome Variability in Pediatric Patients With Inflammatory Bowel Disease

Advanced Gut & Microbiome Research
The gut microbiome is more than just the gastrointestinal tract and the digestive organ. It is a unique community of microbes, the particular composition of which may play an important role in the development of disease, including inflammatory bowel ...
Katerina Maeder, Mytien Nguyen
doaj   +1 more source

The Keystone‐Pathogen Hypothesis Updated: The Role of Porphyromonas gingivalis in Periodontitis

Journal of Periodontal Research, EarlyView.
Porphyromonas gingivalis orchestrates a coordinated manipulation of immune and inflammatory responses in periodontal tissues which leads to the generation of a dysbiotic, subgingival biofilm community, and progression of periodontitis. The type 9 secretion system, lipid A modification, and the formation of outer membrane vesicles are important ...
Mike A. Curtis, James A. Garnett, Richard P. Darveau   +2 more
wiley   +1 more source